MRI techniques to monitor MS evolution
Data up to Jan 2025
Total Citations Per Year
Abstract
References (92)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
2001 • 6,888 citations
Axonal Transection in the Lesions of Multiple Sclerosis
1998 • 4,007 citations
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
1993 • 3,535 citations
Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging
1997 • 1,460 citations
Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions
2001 • 1,377 citations
Cortical lesions in multiple sclerosis
1999 • 767 citations
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
1999 • 728 citations
Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
1999 • 713 citations
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis
1998 • 652 citations
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
1991 • 625 citations
Spinal cord atrophy and disability in multiple sclerosis
1996 • 618 citations
Diffusion tensor magnetic resonance imaging in multiple sclerosis
2001 • 543 citations
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions
1994 • 534 citations
Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology
1997 • 517 citations
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
2001 • 507 citations
Axonal damage correlates with disability in patients with relapsing- remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
1998 • 499 citations
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis
1999 • 490 citations
Imaging axonal damage of normal-appearing white matter in multiple sclerosis
1998 • 483 citations
Progressive cerebral atrophy in multiple sclerosis A serial MRI study
1996 • 482 citations
Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging
2000 • 470 citations
Accumulation of hypointense lesions ("black holes") on T 1 spin-echo MRI correlates with disease progression in multiple sclerosis
1996 • 451 citations
Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis
2000 • 404 citations
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis
1993 • 378 citations
Correlation of magnetization transfer ration with clinical disability in multiple sclerosis
1994 • 335 citations
Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis
2000 • 313 citations
Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis
2001 • 289 citations
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study.
1990 • 285 citations
The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis
2000 • 269 citations
Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis
1998 • 268 citations
Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR.
1998 • 266 citations
Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis.
2001 • 238 citations
Quantitative volumetric magnetization transfer analysis in multiple sclerosis: Estimation of macroscopic and microscopic disease burden
1996 • 236 citations
Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI
1999 • 234 citations
Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage
2002 • 222 citations
Biochemical alterations in multiple sclerosis lesions and normal‐appearing white matter detected by in vivo 31P and 1H spectroscopic imaging
1994 • 219 citations
A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions
2001 • 215 citations
Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS
2000 • 208 citations
In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance
1999 • 208 citations
A serial study of new MS lesions and the white matter from which they arise
1998 • 201 citations
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
1994 • 197 citations
Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis
2000 • 195 citations
Total brain N -acetylaspartate
2000 • 188 citations
Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI
2000 • 185 citations
A magnetization transfer histogram study of normal-appearing brain tissue in MS
2000 • 180 citations
Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease
1998 • 180 citations
Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI
2001 • 178 citations
Correlation of volumetric magnetization transfer imaging with clinical data in MS
1998 • 170 citations
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy
1996 • 170 citations
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis
1998 • 166 citations
Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer.
1995 • 158 citations
Short-term brain volume change in relapsing-remitting multiple sclerosis: Effect of glatiramer acetate and implications
2001 • 156 citations
Diffusion imaging of the spinal cord in vivo: Estimation of the principal diffusivities and application to multiple sclerosis
2000 • 147 citations
Magnetization transfer imaging to monitor the evolution of MS
2000 • 146 citations
Dyke Award paper. MR of wallerian degeneration in the feline visual system: characterization by magnetization transfer rate with histopathologic correlation.
1994 • 140 citations
Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis.
1999 • 140 citations
Linomide in relapsing and secondary progressive MS
2000 • 135 citations
A conventional and magnetization transfer MRI study of the cervical cord in patients with MS
2000 • 134 citations
A longitudinal study of T1 hypointense lesions in relapsing MS
2000 • 134 citations
Hypointense Lesions on T1-Weighted Spin-Echo Magnetic Resonance Imaging
2001 • 133 citations
Magnetization Transfer Ratio Histogram Analysis of Gray Matter in Relapsing-remitting Multiple Sclerosis
2001 • 131 citations
Whole brain volume changes in patients with progressive MS treated with cladribine
2000 • 123 citations
Whole-brain diffusion MR histograms differ between MS subtypes
2000 • 120 citations
A multicenter measurement of magnetization transfer ratio in normal white matter
1999 • 112 citations
Early structural changes in acute MS lesions assessed by serial magnetization transfer studies
1998 • 108 citations
Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging.
2000 • 105 citations
Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis.
1999 • 102 citations
MR proton spectroscopy in multiple sclerosis.
1992 • 101 citations
Correlates of MS disability assessed in vivo using aggregates of MR quantities
2001 • 92 citations
Magnetization Transfer Imaging of Diffuse Axonal Injury Following Experimental Brain Injury in the Pig: Characterization by Magnetization Transfer Ratio with Histopathologic Correlation
1996 • 90 citations
Diffusion‐weighted imaging of the human optic nerve: A New approach to evaluate optic neuritis in multiple sclerosis
1997 • 88 citations
Insulin Secretion and Acetylcholinesterase Activity in Monosodium <i>L</i>-Glutamate-Induced Obese Mice
2000 • 85 citations
Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis
2000 • 83 citations
Magnetization transfer ratios in multiple sclerosis lesions enhancing after different doses of gadolinium
1998 • 78 citations
Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T
1996 • 77 citations
Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T1, T2 and MT histograms
1999 • 71 citations
Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy
2001 • 70 citations
Characteristics of chronic MS lesions in the cerebrum, brainstem, spinal cord, and optic nerve on T1‐‐‐weighted MRI
1998 • 69 citations
Magnetization-transfer histogram analysis of the cervical cord in patients with multiple sclerosis.
1999 • 54 citations
Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS.
2001 • 52 citations
Magnetization transfer ratios of multiple sclerosis lesions with variable durations of enhancement
1998 • 51 citations
Linking structural, metabolic and functional changes in multiple sclerosis
2001 • 51 citations
Placebo‐controlled clinical trials in multiple sclerosis: Ethical considerations
2001 • 39 citations
Reproducibility of magnetization transfer ratio histogram-derived measures of the brain in healthy volunteers.
2000 • 33 citations
Multiple sclerosis: a white matter disease with associated gray matter damage
2001 • 31 citations
Multiple sclerosis: more than inflammation and demyelination
2001 • 31 citations
Access www.neurology.org now for full-text articles
2000 • 31 citations
A Novel Nonsense Mutation of the KAL Gene in Two Brothers withKallmann Syndrome
2000 • 28 citations
Exacerbation of postural tremor with emergence of parkinsonism after treatment with neuroleptic drugs.
1995 • 16 citations
Transcriptional activation of the non-muscle, full-length dystrophin isoforms in Duchenne muscular dystrophy skeletal muscle
2001 • 11 citations
Axonal Injury and Disability in Multiple Sclerosis: Magnetic Resonance Spectroscopy as a Measure of Dynamic Pathological Change in White Matter
2001 • 10 citations
Calendar
1999 • 7 citations
Optimization and Standardization of Magnetic Resonance Spectroscopy Techniques for Multicenter Longitudinal Multiple Sclerosis Studies
2001 • 1 citations